S
Susan G. Fisher
Researcher at University of Rochester
Publications - 147
Citations - 14252
Susan G. Fisher is an academic researcher from University of Rochester. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 55, co-authored 147 publications receiving 13490 citations. Previous affiliations of Susan G. Fisher include Georgetown University Medical Center & Free University of Berlin.
Papers
More filters
Journal ArticleDOI
Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
Gregory T. Wolf,Susan G. Fisher,Waun Ki Hong,Robert E. Hillman,Monica Spaulding,George E. Laramore,James W Endicott,Kenneth McClatchey,William G. Henderson +8 more
TL;DR: Preliminary results suggest a new role for chemotherapy in patients with advanced laryngeal cancer and indicate that a treatment strategy involving induction chemotherapy and definitive radiation therapy can be effective in preserving the larynx in a high percentage of patients, without compromising overall survival.
Journal ArticleDOI
Plasma phospholipids identify antecedent memory impairment in older adults
Mark Mapstone,Amrita K. Cheema,Massimo S. Fiandaca,Xiaogang Zhong,Timothy R. Mhyre,Linda MacArthur,William J. Hall,Susan G. Fisher,Derick R. Peterson,James M Haley,Michael Nazar,Steven A. Rich,Dan J Berlau,Carrie B. Peltz,Ming Tan,Claudia H. Kawas,Howard J. Federoff +16 more
TL;DR: This work discovered and validated a set of ten lipids from peripheral blood that predicted phenoconversion to either amnestic mild cognitive impairment or Alzheimer's disease within a 2–3 year timeframe with over 90% accuracy and may be sensitive to early neurodegeneration of preclinical Alzheimer’s disease.
Journal ArticleDOI
Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients.
Lode J. Swinnen,Costanzo-Nordin Mr,Susan G. Fisher,E J O'Sullivan,E J O'Sullivan,M R Johnson,M R Johnson,A L Heroux,A L Heroux,G J Dizikes,G J Dizikes,Roque Pifarré,Roque Pifarré,Richard I. Fisher,Richard I. Fisher +14 more
TL;DR: The addition of OKT3 to the immunosuppressive regimen increases the incidence of post-transplantation lymphoproliferative disorder after cardiac transplantation, and the risk increases sharply after cumulative doses greater than 75 mg.
Journal ArticleDOI
Spontaneous Conversion and Maintenance of Sinus Rhythm by Amiodarone in Patients With Heart Failure and Atrial Fibrillation Observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT)
Prakash Deedwania,Bramah N. Singh,Kenneth A. Ellenbogen,Susan G. Fisher,Ross D. Fletcher,Steven N. Singh +5 more
TL;DR: In patients with CHF, amiodarone has a significant potential to spontaneously convert patients in AF to sinus rhythm, with patients who convert having a lower mortality rate than those who do not, and the drug prevented the development of new-onset AF and significantly reduced the VR in those with persistent AF.
Journal ArticleDOI
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
David G. Pfister,Scott A. Laurie,Gregory S. Weinstein,William M. Mendenhall,David J. Adelstein,Kie-Kian Ang,Gary Clayman,Susan G. Fisher,Arlene A. Forastiere,Louis B. Harrison,Jean-Louis Lefebvre,Nancy Leupold,Marcy A. List,Bernard O'Malley,Snehal G. Patel,Marshall R. Posner,Michael A. Schwartz,Gregory T. Wolf +17 more
TL;DR: Evidence supports the use of larynx-preservation approaches for appropriately selected patients without a compromise in survival; however, no larynic cancer treatment approach offers a survival advantage compared with total laryngectomy and adjuvant therapy with rehabilitation as indicated.